News
Find us at the next congress “Drug Discovery 2017” in Liverpool
The leading lights in drug discovery research across pharma, biotech, academia and the vendor community !
HCS, HCA & Biology
Development of High-content Assays for Compound Screening and Hit Validation
In this presentation, Dr. Kamyar Hadian (head of the #assay development and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany) talk about #hcs use in #stem cell– and microtissue-based assays. #phenotypic screening has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field Read more…